BeStock  
Stocks › Biotechnology › BNTX

BioNTech BNTX

US equityMarket cap rank #505BiotechnologyInfectious Disease
$97.26 −$1.05 (-1.06%)
Market open · Oct 1, 1:10 pm ET · After hours $98.30 0.00%
Open$97.59
Prev close$98.30
Day range$97.13 – $99.41
Volume300.0K
Market cap$24.43B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-12.9x
CheapRich

Around its usual level · 41st percentile, 5-year average -4.5x

Price / book1.2x
CheapRich

Around its usual level · 51st percentile, 5-year average 1.8x

#1697 of 5307 stocks by PB (1 = cheapest)

Price / sales8.3x
CheapRich

Near the top of its 5-year range · 88th percentile, 5-year average 5.1x

#4284 of 5144 stocks by PS (1 = cheapest)

Morningstar fair value estimate

Fair value$76.00
Price vs. fair value+28.0%Trading above the estimate
Star rating★★☆☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.23 – 1.82 51% (pricier than usual) #1697 of 5307 (1 = cheapest)
PE -12.93 -16.31 -4.51 41% (cheaper than usual) –
PS 8.27 11.82 5.06 88% (pricier than usual) #4284 of 5144 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★
Fair value estimate$76.00
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on BNTX.

Leave a comment

Scroll to Top